Log in

Relevant bibliographies by topics / Kaba Sura Kudineer

Contents

Journal articles

Academic literature on the topic 'Kaba Sura Kudineer'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Kaba Sura Kudineer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Kaba Sura Kudineer"

1

Gopalasatheeskumar, K., Karthikeyen Lakshmanan, Anguraj Moulishankar, Jerad Suresh, D. Kumuthaveni Babu, and V. K. Kalaichelvan. "Screening of Kabasura Kudineer Chooranam against COVID-19 through Targeting of Main Protease and RNA-Dependent RNA Polymerase of SARS-CoV-2 by Molecular Docking Studies." Asian Journal of Organic & Medicinal Chemistry 5, no. 4 (2020): 319–31. http://dx.doi.org/10.14233/ajomc.2020.ajomc-p299.

Full text

Abstract:

COVID-19 is the infectious pandemic disease caused by the novel coronavirus. The COVID-19 is spread globally in a short span of time. The Ministry of AYUSH, India which promotes Siddha and other Indian system of medicine recommends the use of formulation like Nilavembu Kudineer and Kaba Sura Kudineer Chooranam (KSKC). The present work seeks to provide the evidence for the action of 74 different constituents of the KSKC formulation acting on two critical targets. That is main protease and SARS-CoV-2 RNAdependent RNA polymerase target through molecular docking studies. The molecular docking was

APA, Harvard, Vancouver, ISO, and other styles

2

Rathinam, Susila, Kannan Muthiah, Sathiyarajeswaran Parameswaran, Kavitha Tamilarasan, Esaivani Selvarajan, and Usha Ayyasamy. "Analogy of Kaba Suram with COVID-19 Symptoms - A Siddha Literature Review." International Journal of Ayurvedic Medicine 11, no. 4 (2020): 616–21. http://dx.doi.org/10.47552/ijam.v11i4.1674.

Full text

Abstract:

Kaba Suram (phlegmatic fever) is one among the 64 types of Suram (Pyrexia/fever), its synonyms, causes, pathology and characteristics have been mentioned crystal clear in Siddha literature. Its clinical features have been mentioned in few literatures such as Theran karisal, Suravagadam, Yugi chinthamani etc., which are almost similar to each other. The present day pandemic disease COVID-19 which still lacks specific drug towards its management or prophylaxis has become the spectrum of research focus in current scenario. Upon keen understanding of the Siddha literature the signs and symptoms of

APA, Harvard, Vancouver, ISO, and other styles

3

Jose, Svenia P., Ratheesh M, Sheethal S, et al. "Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced inflammatory response in RAW-264.7 macrophages cells." Journal of Ethnopharmacology 283 (January 2022): 114738. http://dx.doi.org/10.1016/j.jep.2021.114738.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

T, Peter, and Aruna Ajithadas. "Prevention and treatment of COVID – 19: A review." World Journal of Advanced Research and Reviews 09, no. 03 (2021): 272–80. https://doi.org/10.5281/zenodo.4660847.

Full text

Abstract:

Coronavirus, are belonging to the family Coronaviridae. Corona viruses have enveloped virions (virus particles) that measure approximately 120 nm (1 nm = 10−9 meter) in diameter. Coronaviridae is generally considered to contain two genera, Coronavirus and Torovirus.  It was the first coronavirus to be isolated from domestic fowls in the late `known as SARS corona virus. COVID-19 is a disease caused by a new strain of corona virus. 'CO' stands for corona, 'VI' for virus, and 'D' for disease. Formerly, this disease was referred to as '2019 novel corona viru

APA, Harvard, Vancouver, ISO, and other styles

5

s, veera kannan. "Efficacy of Two Siddha Polyherbal Decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, Along with Standard Allopathy Treatment in the Management of Mild to Moderate Symptomatic COVID-19 Patients—A Double-Blind, Placebo-Controlled, Clinical Trial." January 6, 2025. https://doi.org/10.5281/zenodo.14604146.

Full text

Abstract:

The global search for effective treatments against the SARS-CoV-2 virus has yielded limited success. Indian traditional medicine systems, particularly Siddha, offer potential therapeutic options. This study investigates the efficacy of two Siddha polyherbal formulations, Nilavembu Kudineer (NVK) and Kaba Sura Kudineer (KSK), when administered alongside standard allopathy treatment for mild to moderate symptomatic COVID-19

APA, Harvard, Vancouver, ISO, and other styles

6

Thillaivanan.S, Mubarak H, Susikannamma.S, and Parthiban P. "A REVIEW ON SIDDHA SASTRIC MEDICINES EFFECTIVE IN COVID-19 MANAGEMENT AT TPEC COVID CARE CENTRE, VELLORE." International Journal of Ayurveda and Pharma Research, July 1, 2021, 56–61. http://dx.doi.org/10.47070/ijapr.v9i5.1923.

Full text

Abstract:

Covid-19 is a novel virus that occurs in humans and travels globally very rapidly from person to person. Coronavirus disease is a critical challenge in high population countries such as India. The rising expense of western medicine and its adverse reactions has become an important challenge against Covid-19. Nowadays the traditional medical system and its preparations are for various ailments becoming more popular. South Asia's one of the ancient medicine is the Siddha system of medicine. Kaba Sura Kudineer (KSK) has become a popular Siddha medicine on this pandemic. Previously, Nilavembu Kudi

APA, Harvard, Vancouver, ISO, and other styles

7

"Indian herbal formulation Kaba Sura Kudineer possesses the most powerful ligands to block ACE2-RBD interaction of SARS-CoV-2 infection." Indian Journal of Traditional Knowledge 20, no. 4 (2021). http://dx.doi.org/10.56042/ijtk.v20i4.40383.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Srivastava, Anurag, Manickavasagam Rengaraju, Saurabh Srivastava, et al. "Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients—a double-blind, placebo-controlled, clinical trial." Trials 22, no. 1 (2021). http://dx.doi.org/10.1186/s13063-021-05478-0.

Full text

Abstract:

Abstract Background and aim Globally, the ongoing pursuit in exploring an effective drug to combat severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has not met with significant success to date. Indian traditional medicines, especially polyherbal formulations like Nilavembu Kudineer (NVK) and Kaba Sura Kudineer (KSK) of the Siddha system of medicine, have been used as public health interventions for controlling viral epidemics like dengue and Chikungunya. These traditional therapies have been found safe, effective, and widely accepted. The current study evaluates the comparati

APA, Harvard, Vancouver, ISO, and other styles

9

Srivastava, Anurag, Manickavasagam Rengaraju, Saurabh Srivastava, Vimal Narayan, Vivek Gupta, and Rashmi Upadhayay. "A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial." Trials 22, no. 1 (2021). http://dx.doi.org/10.1186/s13063-021-05041-x.

Full text

Abstract:

Abstract Objectives The primary objectives of the study are to determine the effectiveness of the Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy Treatment to compared with Placebo (Decaffeinated Tea) with standard Allopathy Treatment in the management of Symptomatic COVID 19 patients and also in reduction of Hospital Stay Time & Changes in Immunological (IL6) and Bio Chemical Markers (Ferritin, CRP, D-Dimer and LDH). The secondary objectives are to evaluate the safety of the trial medicines and their effects in the reduce the risks of the disease. In

APA, Harvard, Vancouver, ISO, and other styles

10

Karunanithi, Samraj, Sreenivasa Rao P, Nandhagopal K, et al. "Survival Analysis Based on the Siddha Body Constitution of Asymptomatic SARS-CoV-2 Patients Under Integrative Management of Hydroxychloroquine (HCQ) and Kaba Sura Kudineer (KSK): A Retrospective, Cross-Sectional, Case Series in Tirupati." Current Traditional Medicine 07 (August 10, 2021). http://dx.doi.org/10.2174/2215083807666210810113120.

Full text

Abstract:

Objective: To analyse the duration of hospital stay of asymptomatic COVID-19 patients in Integrated Medical care of Hydroxychloroquine and Kaba Sura Kudineer (Herbal decoction). Design: A retrospective case series of 19 asymptomatic confirmed SARS-Cov-2 patients from District COVID Care Centre, Tirupati, India, between 23rd May to 7th June 2020. Method: Clinical data were collected using a standardised case report form containing demographic information, length of hospital stays and Siddha Yakkai Ilakkanam (Body Constitution) from the records. The association between length of hospital stay, a

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!